The Relation between Homocysteine Levels in Patients with Acute Coronary Syndrome and Grace Score

Overall, despite the low figures, a meaningful positive relation was observed between homocysteineand GRACE risk score in all cases.Conclusion: Homocysteine is independent of other classic risk factors for cardiovascular diseases.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Objectives: This study investigated the correlation between homocysteine levels in patients with Acute Coronary Syndrome andGRACE Score.Methods: This study included 191 cases -140 Non-ST MI cases and 51 MI with ST-elevation cases in Şişli Etfal Training and ResearchHospital Coronary Intensive Care Unit between December 2008 and March 2010.

📊

Key Findings & Data:Homocysteine was measured by immulite 2000device, using kemiluminesans method and competitive immunoassay principle and a kit by DPC was used during the measurement.The reference range given by the producing company was between 5-15 Mmol/L for male and female adults.

💡

Conclusion & Impact:Overall, despite the low figures, a meaningful positive relation was observed between homocysteineand GRACE risk score in all cases.Conclusion: Homocysteine is independent of other classic risk factors for cardiovascular diseases.

🔬Design:Research Article

📍Scope:2008 Verileri

⚙️Variables:Domain Parameters

Özet

Objectives: This study investigated the correlation between homocysteine levels in patients with Acute Coronary Syndrome andGRACE Score.Methods: This study included 191 cases -140 Non-ST MI cases and 51 MI with ST-elevation cases in Şişli Etfal Training and ResearchHospital Coronary Intensive Care Unit between December 2008 and March 2010. Homocysteine was measured by immulite 2000device, using kemiluminesans method and competitive immunoassay principle and a kit by DPC was used during the measurement.The reference range given by the producing company was between 5-15 Mmol/L for male and female adults. The patients were classifiedinto three risk groups as low, medium and high on the basis of the criteria identified in GRACE risk score: age, heart rate, systolicblood pressure, serum creatine levels, Killip classification, cardiac arrest on admission, increased cardiac enzymes and ST segment depression.The relation between homocysteine levels in patients with Acute Coronary Syndrome and GRACE risk score was evaluated.Results: In the Non-ST MI group, a statistically-moderate positive correlation was seen between homocysteine and GRACE riskscore during the study (p 0.05). Overall, despite the low figures, a meaningful positive relation was observed between homocysteineand GRACE risk score in all cases.Conclusion: Homocysteine is independent of other classic risk factors for cardiovascular diseases. Therefore, we believe that routineplasma homocysteine levels should be checked when evaluating risk factors for Atherosclerotic Coronary Artery disease.

🔖

Cite This Article

ÇALIM, A., TÜRKÖZ, F. P., ÖZTÜRKMEN, Y. A., MAZI, E. E., ÇETİN, E. G., DEMIR, N., BORLU, F. (2020). The Relation between Homocysteine Levels in Patients with Acute Coronary Syndrome and Grace Score. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 54 - Sayı: 3, 346–350. https://ajindex.com/articles/363670

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (13)

Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med 1998;4:1241–3
TEKHARF; Oniki Yıllık İzleme Deneyimine Göre Türk Erişkinlerinde Kalp Sağlığı. Prof. Dr. Altan Onat, Prof. Dr. Vedat Sansoy, Prof. Dr. İnan Soydan, Prof. Dr. Lale Tokgözoğlu, Prof. Dr. Kamil Adalet. İstanbul: Argos; 2003
Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 1988;8:737–41
Grayston JT, Kuo CC, Wang SP, Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986;315:161–8
Malinow MR, Kang SS, Taylor LM, Wong PW, Coull B, Inahara T, et al. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 1989.;79:1180–8
Harker LA, Ross R, Slichter SJ, Scott CR. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest 1976;58:731–41
Solberg LA, Enger SC, Hjermann I, Helgeland A, Holme I, Leren P, et al: Risk factors for coronary and cerebral atherosclerosis. Oslo Study In Atherosclerosis V. In: Gotto AM, Smith LC, Allen B, editors. New York, NY: Springer Verlag; 1980. p. 57–62
Ueland PM, Refsum H, Brattstrom L. Plasma homocysteine and cardiovascular disease. In: Francis RB Jr, editor. Atherosclerotic cardiovascular disease, hemostasis, and endothelial function. New York: Marcel Dekker; 1992. p. 183–236
Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049–57
Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996;27:517–27. 11. de Araújo Gonçalves P, Ferreira J, Aguiar C, Seabra-Gomes R. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J 2005;26:865–72
Tokgözoğlu SL, Alikaşifoğlu M, Unsal, Atalar E, Aytemir K, Ozer N, et al. Methylene tetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate. Heart 1999;81:518–22
Nygård O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995;274:1526– 33
Tsai WC, Li YH, Tsai LM, Chao